Saba Capital Management, L.P. sold HQL

September 15, 2025 · Form 4 insider transaction

Saba Capital Management, L.P. sold 700 shares of Abrdn Life Sciences Investors at $14.13 per share, a transaction worth $9.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.